Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial

• Egile Nagusiak: Hiroko Kotajima‐Murakami (Egilea), Ayumi Takano (Egilea), Yasukazu Ogai (Egilea), Shotaro Tsukamoto (Egilea), Maki Murakami (Egilea), Daisuke Funada (Egilea), Yuko Tanibuchi (Egilea), Hisateru Tachimori (Egilea), Kazushi Maruo (Egilea), Tsuyoshi Sasaki (Egilea), Toshihiko Matsumoto (Egilea), Kazutaka Ikeda (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2019-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Aims Pharmacotherapy for methamphetamine dependence has not yet been developed in Japan or elsewhere in the world. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels that play a key role in the mechanism of action of addictive substances. Our aim is to exa...